Although rare, stent thrombosis remains a severe complication after stent implantation owing
to its high morbidity and mortality. Since the introduction of drug-eluting stents (DES), most …

Polymer-based sirolimus-(Cypher) and paclitaxel-eluting (Taxus) drug eluting stents have
become the treatment of choice for patients with symptomatic coronary artery disease …

Inhibitors of mechanistic target of rapamycin (mTOR inhibitors) are used as antiproliferative
immunosuppressive drugs and have many clinical applications in various drug …

Objectives: The purpose of this study was to assess trends in endothelial coverage and
recovery among leading polymer-based drug-eluting stents (DES). Background: Autopsy …

Tissue factor (TF), formerly known as thromboplastin, is the key initiator of the coagulation
cascade; it binds factor VIIa resulting in activation of factor IX and factor X, ultimately leading …

Recently investigated applications of polymeric materials for tissue engineering,
regenerative medicine, implants, stents, and medical devices are described in the present …

Objectives: We sought to determine the risk of late stent thrombosis (ST) during long-term
follow-up beyond 3 years, searched for predictors, and assessed the impact of ST on overall …

this form of selective reporting, it is recommended that both primary ST rates (without
intercurrent target lesion revascularization) and secondary ST rates (with intercurrent target …

Coronary heart disease (CHD) is a type of cardiovascular disease with the highest mortality
rate worldwide. Percutaneous transluminal coronary intervention (PCI) is the most effective …

Percutaneous coronary intervention (PCI) has become the most common revascularization
procedure for coronary artery disease. The use of stents has reduced the rate of restenosis …